OncoCyte Corp (NAS:OCX)
$ 2.435 -0.095 (-3.75%) Market Cap: 40.99 Mil Enterprise Value: 43.22 Mil PE Ratio: 0 PB Ratio: 3.34 GF Score: 31/100

OncoCyte Corp to Acquire Insight Genetics Inc - Conference Call Transcript

Jan 10, 2020 / 09:30PM GMT
Release Date Price: $53 (+6.43%)
Operator

Greetings. Welcome to the OncoCyte conference call to discuss the agreement to acquire Insight Genetics. (Operator Instructions) Please note this conference is being recorded.

I will now turn the conference over to your host, Ronnie Andrews, Chief Executive Officer. Mr. Andrews, you may begin.

Ronald A. Andrews
OncoCyte Corporation - CEO, President & Director

Yes. Bob, you need to go first.

Robert A. Yedid
LifeSci Advisors, LLC - MD

Yes. Why don't I start? Why don't I start? It's Bob Yedid from LifeSci Advisors. And before Ronnie starts, and I hate to cut him off there, we're just going to read some forward-looking statement. And thank you, operator, and thanks, everyone, for joining us for today's conference call to discuss the definitive agreement to acquire Insight Genetics. If you have not seen today's press release, please visit OncoCyte's website at www.oncocyte.com. In addition, there will be slides that will accompany this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot